NCT07039799Recruiting
The Effect of Virtual Reality Applications on Upper Extremity Functions in Patients With Duchenne Muscular Dystrophy
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
This study aims to evaluate the effects of fully immersive virtual reality (VR) applications on upper extremity (UE) functions in individuals diagnosed with Duchenne Muscular Dystrophy (DMD). DMD is a progressive neuromuscular disorder that leads to muscle weakness and loss of function, including the upper limbs, which are essential for daily activities and independence. In this randomized controlled trial, 36 participants with DMD will be divided into two groups: a control group receiving conventional physiotherapy and an intervention group receiving the same physiotherapy program (excluding upper extremity exercises) combined with VR-based exercises. The VR games will be designed specifically to improve shoulder, elbow, wrist, and hand functions and will be delivered using Meta Quest 3 headsets with hand-tracking capabilities. Both groups will receive therapy twice a week for 8 weeks. Assessments will be conducted before and after the intervention, and at follow-up, using validated tools to measure UE function, grip strength, fine motor skills, trunk control, fatigue, quality of life, and participation in daily activities. The study aims to explore innovative rehabilitation strategies for DMD and contribute to improving the independence and quality of life of affected individuals.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- First submitted
- 18 Jun 2025
- Start date
- 15 Aug 2025
- Primary completion date
- 15 Feb 2027
- Lead sponsor
- Istanbul University
- Diseases
- Duchenne muscular dystrophy
- NCT number
- NCT07039799
What you commit to
- Study type: Interventional
- Planned participants: 36
- From 15 Aug 2025 to the primary completion date, 15 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Systemic illness or condition interfering with participation
Other
- Presence of any neurological diagnosis other than DMD
- Cognitive, behavioral, or communication impairments that limit participation
- Severe visual impairments incompatible with VR headset use
- Presence of severe contractures or deformities that prevent execution of VR-based exercises
Who the study is looking for
- Clinical diagnosis of Duchenne Muscular Dystrophy (DMD)
- Age ≥ 7 years
- Ambulatory or non-ambulatory status (both are eligible)
- Ability to follow movement instructions
- Brooke Upper Extremity Functional Rating Scale (BUEFS) level ≤ 4 (i.e., able to bring hand to mouth)
Age in the registry: 7 years to 18 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.